Aishwarya Narayanan

Sr. Solutions Architect at Elucidata

Aishwarya Narayanan has a rich and diverse work experience. Aishwarya is currently working as a Sr. Solutions Architect at Elucidata since April 2021. Prior to this, they worked as a Business Development Manager at Strand Life Sciences from December 2018 to June 2020.

Before joining Strand Life Sciences, Aishwarya was associated with MEDGENOME as a Product Manager from July 2017 to October 2018. In this role, they defined the product roadmap for the OncoMD somatic mutation database and improved data curation and validation processes to enable its usage for clinical interpretation and reporting. Aishwarya managed a team of 9 members and collaborated closely with software, bioinformatics, marketing, and R&D teams.

From August 2016 to July 2017, Aishwarya worked as a Principal Scientist at Syngene International Limited. Their responsibilities included handling the complete life cycle of NGS data analysis projects for big pharma clients. Aishwarya gained experience in various genomics applications such as DNA/RNA Seq and antibody sequencing, along with data analysis for genomics-based clinical trials.

Aishwarya's career journey began in 2007 at Strand Life Sciences, where they worked as a Senior Application Scientist. Their initial role focused on the development, testing, and documentation of microarray and NGS data analysis software products. Aishwarya later expanded their responsibilities to include customer interactions, leading to collaborative projects, data analysis services, and publications. Their tenure at Strand Life Sciences lasted until July 2016.

Overall, Aishwarya Narayanan's work experience showcases their expertise in genomics-based solutions and their ability to manage teams, collaborate with different stakeholders, and drive product development and business growth.

Aishwarya Narayanan holds a Master's degree from Madurai Kamaraj University.

Location

Bengaluru, India

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Elucidata

5 followers

Elucidata offers 10x faster identification of therapeutic assets with high odds of success in the clinic. It has enabled the detection of multiple validated drug targets across immunology, oncology, and metabolic disorders. Elucidata supports discovery programs at Pfizer, Agios Pharmaceuticals, Genentech, and Yale and has 35+ research partners from premier biopharma companies and research labs.


Industries

Employees

51-200

Links